Eligen B12

About Eligen B12

Eligen B12 is the first and only once-daily oral prescription medical food shown to normalize B12 levels without the need for an injection. Eligen B12 is indicated for the dietary management of patients who have a medically-diagnosed vitamin B12 deficiency, associated with a disease or condition that cannot be managed by a modification of the normal diet alone. Eligen B12 is the first product to market using Emisphere’s advanced Eligen® Technology, which utilizes a carrier, salcaprozate sodium or SNAC, to chaperone B12 through the gastric lining and directly into the bloodstream independent of intrinsic factor, a protein made in the stomach that normally facilitates B12 absorption. This groundbreaking technology may have potential application across a broad range of diseases and conditions. Most notably, Eligen® Technology is being used to develop oral formulations of insulin and GLP-1 receptor agonists. Learn more about Eligen B12 at  www.EligenB12.com.

For more information on licensing Eligen B12 as either a prescription medical food, an OTC medical food or an OTC nutritional supplement please click here.

EligenB12.com

Visit Site

Eligen B12 Information

Eligen B12 Fact Sheet

Download

Eligen B12 Package Insert

Download

Pharmacokinetic Study

Download

Pharmacodynamics Study

Download

Endocrinology Fact Sheet

Download

Women’s Health Fact Sheet

Download

Gastroenterology Fact Sheet

Download

Neurology Fact Sheet

Download

Bariatric Surgery Fact Sheet

Download

Physician Brochure

Download

Patient Brochure

Download